focus
Business Development
” Rasayani Biologics strives to provide, easy to administer, economic and effective therapies for prevention of critical illnesses. “
- Driving Innovation
- Salient Features
- Business Approach
Driving Innovation
Organize and implement modern methods of scientific research in “State-of-the-Art” Lab and clinical studies for select promising drugs.
Drugs are based on reverse pharmacology, thus reducing the uncertainties in clinical development substantially.
Patent scientific breakthroughs / achievements.
Out licencing opportunities of the clinical stage unique Drug candidates.
CRO for Physico-Chemical characterization work in vitro, in vivo, proof of concept work and Clinical Trial Management.
Salient Features
- RBPL specializes at synthesizing nano Particles of Noble Metals and Base Elements using Patented platform technology.
- The Metals are converted into bio-compatible & therapeutically effective form using unique green technology process.
- Environment friendly process, involves no use of any harmful chemicals unlike conventional nano material synthesis.
Business Approach
- We are aware that exploring complex therapeutic challenges needs a networking of varied scientific disciplines and a sound financial acumen. We look to partner with the best and brightest in the industry to challenge the conventional drug development, think beyond economics and make a lasting impression on the therapeutic landscape of all critical illnesses.
- The partnership deals can be structured to leverage our unique attributes and the strong points of the partner in the convergent ways to carry forward the drug development with a singular aim of providing eternal-patient centric solutions.
- We strongly believe in building partnerships that create value for everyone involved and is based on unwavering trust as a foundation. We are open to collaborate on the pipeline drugs which are in the different phases of developmental pathways.